About Ipsen

Ipsen is a global biopharmaceutical company focused on areas where medical solutions remain scarce. The company develops and commercialises innovative treatments across three therapeutic areas: oncology, rare diseases, and neuroscience. With therapies for neuroendocrine tumors, rare bone disorders, and neurological conditions, Ipsen targets patient populations who face limited options. The company combines global reach with mid-sized agility. Over 5,500 professionals across five continents advance a robust pipeline, forge partnerships with biotechs and academic institutions, and navigate regulatory pathways. Ipsen directs resources where they create the greatest patient impact.